Comparison of the clinical value of CA 19-9 versus CA 125 for the diagnosis of endometriosis
article
OA: closed
CC0
⤵ 39 in-corpus citations
AI-generated summary
This study compared the diagnostic value of CA 19-9 and CA 125 for detecting endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Preoperative blood samples and intraoperative tissue specimens were obtained from 101 patients with endometriosis and 78 patients without endometriosis referred for benign gynecologic operations to investigate the clinical value of serum and tissue CA 19-9 levels in the diagnostic evaluation of endometriosis as compared to CA 125. Our prospective cohort study showed that serum CA 19-9 is a valuable marker in the diagnosis of endometriosis, and it may be used to predict the patients with severe endometriosis when used with CA 125.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (6)
- Immunohistochemical analysis of CA125, CA19–9, and Ki-67 in stage III or IV endometriosis: positive correlation between serum CA125 level and endometriotic epithelial cell proliferation via openalex
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
- W1983947024 via openalex
- W2087512818 via openalex
- W2135721067 via openalex
- W6668890459 via openalex
Cited by (40)
- Nano-based Innovations for Reimagining Endometriosis: Next-Gen Diagnostics and Therapeutics Toward Targeted and Transformative Therapy- A Comprehensive Review 2026
- Nanotechnologies for the detection and treatment of endometriosis 2023
- Diagnostic Clues for Women with Acute Surgical Abdomen Associated with Ruptured Endometrioma 2023
- Clinical practice guidelines for endometriosis in Japan (The 3rd edition) 2022
- Extremely high serum CA19-9 level along with elevated D-dimer in assisting detection of ruptured ovarian endometriosis 2022
- Novel Diagnostic Markers for Endometriosis 2021
- Bio-nanocomposite based highly sensitive and label-free electrochemical immunosensor for endometriosis diagnostics application 2021
- The Potential of Non-Invasive Biomarkers for Early Diagnosis of Asymptomatic Patients with Endometriosis 2021
- Role of biomarkers CA-125, CA-15.3 and CA-19.9 in the distinction between endometriomas and ovarian neoplasms 2021
- A Novel Model To Predict Endometriosis in Patients with Ovarian Cysts: A Retrospective Study. 2021
- Evaluation of the Diagnostic Accuracy of the Interview and Physical Examination in the Diagnosis of Endometriosis as the Cause of Chronic Pelvic Pain 2021
- Detection of a novel glycodelin biomarker using electrochemical immunosensor for endometriosis 2020
- Elevated serum CA 19-9 level, combined with D-dimer, could detect the presence of ruptured ovarian endometriosis 2020
- A novel non-invasive molecular biomarker in ovarian endometriosis: estrogen-related receptor α 2020
- Yüksek Serum CA19-9 Seviyeleri ile Seyreden Bir Endometriozis Olgusu 2019
- Heavy black tea consumption and elevated CA 19-9 and CA 125 levels. A case report on a patient with ovarian endometriotic cysts 2019
- Diagnostic value of tumor biomarkers CA125 and CA72-4 in differentiation of epithelial ovarian cancer and endometrioma 2018
- Correlation of CA-125 with different stages of endometriosis 2018
- Identifying biomarkers for non-invasive diagnosis of endometriosis 2016
- Blood biomarkers for the non-invasive diagnosis of endometriosis 2016
- Serum carcinogenic antigen (CA)-125 and CA 19-9 combining pain score in the diagnosis of pelvic endometriosis in infertile women 2016
- Panel of Autoimmune Markers for Noninvasive Diagnosis of Minimal-Mild Endometriosis: A Multicenter Study 2016
- Diagnostic accuracy of cancer antigen 125 for endometriosis: a systematic review and meta‐analysis 2016
- Clinical significance of serum follistatin levels in the diagnosis of ovarian endometrioma and benign ovarian cysts 2015
- Use of Neutrophil-to-Lymphocyte Ratio Combined With CA-125 to Distinguish Endometriomas From Other Benign Ovarian Cysts 2015
- Diagnostic value of serum CA125, CA19-9 and CA15-3 in endometriosis: A meta-analysis 2015
- Serum Markers for the Noninvasive Diagnosis of Endometriosis 2015
- Reactivity of CA19-9 and CA125 in histological subtypes of epithelial ovarian tumors and ovarian endometriosis. 2015
- Clinical markers of endometriosis: Have we been too quick to judge? 2014
- Copeptin is associated with the severity of endometriosis 2014
- Liver endometriosis presenting as a liver mass associated with high blood levels of tumoral biomarkers 2013
- Endometrioma: From Pathogenesis to Clinical Management 2013
- Evaluation of a panel of 28 biomarkers for the non-invasive diagnosis of endometriosis 2012
- Non-invasive diagnosis of endometriosis with proteomic technologies 2011
- Avaliação do CA-125 e do CD-23 solúvel em pacientes com endometriose pélvica 2011
- Diagnosis of Endometriosis: Biomarkers 2011
- Diagnosis 2011
- Evaluation of serum autoantibody levels in the diagnosis of ovarian endometrioma 2010
- Peripheral biomarkers of endometriosis: a systematic review 2010
- 10.1016/s2211-0666(13)49835-3 2000
Source provenance
- europepmc
- last seen: 2026-08-07T06:07:27.085738+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:13:59.677786+00:00
License: CC0
· commercial use OK